Cell Therapy for the degenerating intervertebral discs
Cell Therapy for the degenerating intervertebral discs
批准号:
7342105
负责人:
YEJIA ZHANG
金额:
$8.31万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-01-20 至 2008-08-31
关键词:
AddressAdenovirusesAllogenicAnimalsAttentionBack PainBasic ScienceBiochemicalBiologicalBone Morphogenetic ProteinsCell CountCell SurvivalCell TherapyCellsChondrocytesClinicalCollagenCollagen Type IIControl GroupsDataDevelopmentDiagnostic radiologic examinationEconomicsEnvironmentEnzyme-Linked Immunosorbent AssayEtiologyExcisionExpression FeatureFluorescence MicroscopyGene TransferGenesGreen Fluorescent ProteinsGrowth FactorHeightHomeostasisImageIn VitroInjection of therapeutic agentInjuryInternationalIntervertebral disc structureLearningLettersLow Back PainMagnetic Resonance ImagingMaintenanceManuscriptsMedicalMentorsMethodsModelingNumbersOperative Surgical ProceduresOryctolagus cuniculusOutcome MeasurePhenotypePhysiciansPhysiologicalProductionProteinsProteoglycanProtonsPublishingPuncture procedureRehabilitation therapyResearchResearch PersonnelReverse Transcriptase Polymerase Chain ReactionRoleScientistSeasonsSurgeonTechnical ExpertiseTechniquesTissuesTodayTrainingTraining ProgramsTransduction GeneTransplantationUnited StatesUniversitiesVertebral columnWeekWeightWorkabstractingaggrecanaging populationbasebone morphogenetic protein 7careercostdensitydesignexperiencegene therapyhuman osteogenic protein 1in vivoindexinginjuredinterestintervertebral disk degenerationprogramsrepairedresearch and developmenttool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The trainee is a young physician with a strong basic science background. With the guidance of the
rehabilitation scientist training program (RMSTP), she has designed a career path that brings together her
scientific and clinical interests. Her research has attracted a considerable amount of positive attention in the
field of rehabilitation. Seven full manuscripts resulted from this work: three have been published, one in
press (see attached manuscript and letter), and three are in review. In addition, 15 abstracts have been
presented at national and international meetings. The proposed research development plan will allow her to
gain additional technical expertise under the guidance of seasoned scientists, and become an independent
clinician-investigator.
The trainee's research plan addresses an immensely important clinical problem, back pain. Although the
etiology of back pain is most likely multi-factorial, intervertebral disc degeneration is perhaps causally
associated with back pain. Biological treatment with a growth factor may promote matrix repair and restore
physiological function. Cell-based gene therapy, which aims at the sustained release of growth factors, will
be explored.
This revised proposal contains new data further supporting the central hypothesis that cell therapy is likely to
represent an effective tool for slowing or even reversing disc degeneration: i) Rabbit intervertebral disc (IVD)
explants injected with allogenic rabbit articular chondrocytes transduced with Ad-hBMP-7 produce more
hBMP-7 protein; ii) Rabbit IVD explants injected with articular chondrocytes expressing hBMP-7 accumulate
more proteoglycans. Based on these findings, she proposes to study the effects of BMP-7 on degenerative
rabbit intervertebral discs using the ex vivo gene transfer method. She has also performed a pilot in vivo
study and transplanted allogenic rabbit articular chondrocytes into the degeneration rabbit IVD,
demonstrating her ability to perform in vivo studies.
Dr. Irving Shapiro, a disc biologist, has assumed the role of her primary mentor. The trainee's in vivo study
will also be helped by Dr. D. Greg Anderson, a spine surgeon,with extensive experience with the animal disc
injury model. In the revised training plan, the trainee proposes to participate in course work and to learn
additional techniques. Thomas Jefferson University provides a rich environment, and has a strong
commitment to support her career development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibition of TNF-alpha Signaling to Reduce Intervertebral Disc Inflammation
-
批准号:10448429
-
项目类别:
-
资助金额:$17.25万
-
财政年份:2021
-
负责人:YEJIA ZHANG
-
依托单位:
Inhibition of TNF-alpha Signaling to Reduce Intervertebral Disc Inflammation
-
批准号:10301274
-
项目类别:
-
资助金额:$21.01万
-
财政年份:2021
-
负责人:YEJIA ZHANG
-
依托单位:
Cell Therapy for the Degenerating Intervertebral Disc
-
批准号:9032599
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:YEJIA ZHANG
-
依托单位:
Cell Therapy for the degenerating intervertebral discs
-
批准号:8010767
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2010
-
负责人:YEJIA ZHANG
-
依托单位:
Cell Therapy for the degenerating intervertebral discs
-
批准号:7687031
-
项目类别:
-
资助金额:$4.65万
-
财政年份:2007
-
负责人:YEJIA ZHANG
-
依托单位:
Cell Therapy for the degenerating intervertebral discs
-
批准号:7752557
-
项目类别:
-
资助金额:$12.83万
-
财政年份:2007
-
负责人:YEJIA ZHANG
-
依托单位:
Cell Therapy for the degenerating intervertebral discs
-
批准号:7544928
-
项目类别:
-
资助金额:$12.83万
-
财政年份:2007
-
负责人:YEJIA ZHANG
-
依托单位:
Cell Therapy for the degenerating intervertebral discs
-
批准号:7212018
-
项目类别:
-
资助金额:$12.95万
-
财政年份:2007
-
负责人:YEJIA ZHANG
-
依托单位:
海外基金